Upgrading the mammalian translation system to probe multi-site post-translational modifications
升级哺乳动物翻译系统以探测多位点翻译后修饰
基本信息
- 批准号:1817893
- 负责人:
- 金额:$ 47.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Proteins are molecular machines that drive the processes underlying biology. The function of proteins are frequently regulated by a wide-variety of reversible chemical modifications, such as acetylation of lysine residues. While numerous such acetylations have been identified on various human proteins, their role in biology remains unclear. Many human proteins are acetylated at multiple different sites, but how these individual modifications contribute to regulation remains poorly understood. The current inability to generate target proteins homogeneously acetylated at a set of chosen sites is a major challenge. This limitation will be overcome by establishing a novel technology. This technology will allow direct modification of a target protein during its synthesis in human cells. This will enable systematic elucidation of how multi-site acetylation regulates protein function. A cross-disciplinary summer research program will be developed to train and motivate high-school students from the greater Boston area. In the last two decades, rapid advances in analytical techniques have identified numerous human proteins that are acetylated at multiple sites. However, the daunting challenge of producing recombinant proteins in a homogeneous state of acetylation been a major roadblock. The genetic code expansion technology offers a powerful strategy to overcome this limitation, by allowing co-translational site-specific incorporation of N (epsilon)-acetyllysine (AcK) into recombinant proteins using an engineered nonsense suppressing aminoacyl-tRNA synthetase/tRNA pair. However, it is currently challenging to incorporate more than one AcK residue per protein in mammalian cells. To address this limitation, systematic engineering of the components of the mammalian translation system that limit the incorporation efficiency of AcK, will be carried out. A novel directed evolution platform for engineering these components based on their performance in live mammalian cells will be developed. The enhanced AcK-incorporation system will be used to interrogate how the function of HMGCS2 is regulated by the acetylation of three different lysine residues. Outreach efforts include a summer research program targeted to local high school students. This program called "You Evolve a Protein!(YEP!)" highlights the use of laboratory evolution to engineer proteins with desired properties. Starting from a fluorescent protein that emits green light, the participant will create engineered variants with altered color.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
蛋白质是驱动生物学基础过程的分子机器。蛋白质的功能经常受到多种可逆化学修饰的调节,例如赖氨酸残基的乙酰化。虽然已经在各种人类蛋白质上鉴定出许多这样的乙酰化,但它们在生物学中的作用仍然不清楚。许多人类蛋白质在多个不同的位点被乙酰化,但这些个体修饰如何促进调控仍然知之甚少。目前无法产生在一组选定位点均匀乙酰化的靶蛋白是一个主要挑战。这一限制将通过建立一种新技术来克服。这项技术将允许在人类细胞合成过程中直接修饰靶蛋白。这将使系统阐明多位点乙酰化如何调节蛋白质功能。将开发一个跨学科的夏季研究计划,以培训和激励来自大波士顿地区的高中生。在过去的二十年中,分析技术的快速发展已经鉴定出许多在多个位点乙酰化的人类蛋白质。然而,在均质乙酰化状态下生产重组蛋白的艰巨挑战一直是一个主要的障碍。遗传密码扩增技术提供了一个强大的策略,以克服这一限制,通过允许共翻译位点特异性掺入N(N)-乙酰赖氨酸(AcK)到重组蛋白质使用工程化的无义抑制氨酰-tRNA合成酶/tRNA对。然而,目前在哺乳动物细胞中每个蛋白质掺入一个以上的AcK残基是具有挑战性的。为了解决这一限制,将对限制AcK掺入效率的哺乳动物翻译系统的组分进行系统工程改造。将开发一种新的定向进化平台,用于根据这些组件在活哺乳动物细胞中的性能对它们进行工程改造。增强的AcK掺入系统将被用来询问HMGCS 2的功能是如何通过三个不同的赖氨酸残基的乙酰化来调节的。外联工作包括针对当地高中生的暑期研究方案。这个项目叫做“你进化出一种蛋白质!(YEP!)“强调了利用实验室进化来设计具有所需特性的蛋白质。参与者将从发射绿色光的荧光蛋白开始,创造出具有改变颜色的工程变体。该奖项反映了NSF的法定使命,并通过使用基金会的智力价值和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Virus-assisted directed evolution of enhanced suppressor tRNAs in mammalian cells
- DOI:10.1038/s41592-022-01706-w
- 发表时间:2022-12-22
- 期刊:
- 影响因子:48
- 作者:Jewel, Delilah;Kelemen, Rachel E. E.;Chatterjee, Abhishek
- 通讯作者:Chatterjee, Abhishek
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Abhishek Chatterjee其他文献
Existing and Evolving Landscape of Medulloblastoma: Towards Optimization and Personalization
髓母细胞瘤现有和不断发展的景观:走向优化和个性化
- DOI:
10.3390/diagnostics14060598 - 发表时间:
2024 - 期刊:
- 影响因子:3.6
- 作者:
Tejpal Gupta;Abhishek Chatterjee - 通讯作者:
Abhishek Chatterjee
Abstract 56. A Cost-utility Analysis Comparing Large Volume Displacement Oncoplastic Surgery to Mastectomy with Free Flap Reconstruction in the Treatment of Breast Cancer
摘要 56. 比较大体积置换肿瘤整形手术与乳房切除术及游离皮瓣重建治疗乳腺癌的成本效益分析
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:1.9
- 作者:
Abhishek Chatterjee;A. Asban;Lilian Chen;Carla Fisher - 通讯作者:
Carla Fisher
Single <em>Versus</em> Dual Surgeon Approaches to Oncoplastic Surgery: A Comparison of Outcomes
- DOI:
10.1016/j.jss.2022.11.067 - 发表时间:
2023-03-01 - 期刊:
- 影响因子:
- 作者:
Manish M. Karamchandani;Gabriel De La Cruz Ku;Kerry A. Gaffney;Carly Wareham;Sarah M. Persing;Christopher Homsy;Salvatore Nardello;Abhishek Chatterjee - 通讯作者:
Abhishek Chatterjee
A financial analysis of payment per unit time for common general surgery operations
- DOI:
10.1016/j.jamcollsurg.2011.06.271 - 发表时间:
2011-09-01 - 期刊:
- 影响因子:
- 作者:
Abhishek Chatterjee;Stefan D. Holubar;Lilian Chen;Shirley A. Montagne;Joseph M. Rosen;Joseph P. Desimone - 通讯作者:
Joseph P. Desimone
ASO Visual Abstract: Does Breast-Conserving Surgery with Radiotherapy Have a Better Survival Than Mastectomy? A Meta-Analysis of More Than 1,500,000 Patients
- DOI:
10.1245/s10434-022-12210-y - 发表时间:
2022-07-18 - 期刊:
- 影响因子:3.500
- 作者:
Gabriel A. De la Cruz-Ku;Manish Karamchandani;Diego Chambergo-Michilot;Alexis R. Narvaez-Rojas;Michael Jonczyk;Fortunato S. Príncipe-Meneses;David Posawatz;Salvatore Nardello;Abhishek Chatterjee - 通讯作者:
Abhishek Chatterjee
Abhishek Chatterjee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Abhishek Chatterjee', 18)}}的其他基金
Bioorthogonal Chemistries Targeting 5-hydroxytryptophan for Biological Discovery and Biologics Development
针对 5-羟色氨酸的生物正交化学用于生物发现和生物制品开发
- 批准号:
2128185 - 财政年份:2021
- 资助金额:
$ 47.5万 - 项目类别:
Standard Grant
相似国自然基金
镉激活神经细胞mTOR通路诱导凋亡及雷帕霉素靶向调控抗凋亡分子机理
- 批准号:30971486
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
相似海外基金
Action of PABP in selectively regulating the mammalian transcriptome
PABP 在选择性调节哺乳动物转录组中的作用
- 批准号:
477623 - 财政年份:2023
- 资助金额:
$ 47.5万 - 项目类别:
Operating Grants
Gene Expression Signature Based Screening in Ewing Sarcoma
基于基因表达特征的尤文肉瘤筛查
- 批准号:
10440705 - 财政年份:2023
- 资助金额:
$ 47.5万 - 项目类别:
Local translation and viral infection in the airway epithelium
气道上皮的局部翻译和病毒感染
- 批准号:
10736284 - 财政年份:2023
- 资助金额:
$ 47.5万 - 项目类别:
Co-translational Regulation in the Vasculature of Organ Systems with Aging
衰老过程中器官系统脉管系统的共翻译调节
- 批准号:
10738940 - 财政年份:2023
- 资助金额:
$ 47.5万 - 项目类别:
Precise in vivo gene editing of HSPC for the treatment of genetic hematologic diseases
HSPC体内精准基因编辑治疗遗传性血液病
- 批准号:
10548540 - 财政年份:2023
- 资助金额:
$ 47.5万 - 项目类别:
Class II Human Leukocyte Antigen biologics for antibody-mediated graft rejection.
用于抗体介导的移植物排斥反应的 II 类人类白细胞抗原生物制剂。
- 批准号:
10598931 - 财政年份:2023
- 资助金额:
$ 47.5万 - 项目类别:
Understanding CDK1 Function and Cancer Vulnerabilities
了解 CDK1 功能和癌症脆弱性
- 批准号:
10736617 - 财政年份:2023
- 资助金额:
$ 47.5万 - 项目类别:
Profiling the Fluid Assisted Dissemination of Pre-malignant cells in Fallopian Tubes
分析输卵管癌前细胞的液体辅助传播
- 批准号:
10718158 - 财政年份:2023
- 资助金额:
$ 47.5万 - 项目类别:
Genome-wide Mapping of Ribosome Occupancies with Inhibitor-Induced mRNA Covalent Labeling
通过抑制剂诱导的 mRNA 共价标记进行核糖体占据的全基因组图谱
- 批准号:
10575642 - 财政年份:2023
- 资助金额:
$ 47.5万 - 项目类别:
Transfer RNAs in Hematopoietic Stem Cell Function
造血干细胞功能中的转移 RNA
- 批准号:
10735318 - 财政年份:2023
- 资助金额:
$ 47.5万 - 项目类别: